Home Investing Clinical trial data shows RAD 101 detects Brain Metastases
Investing

Clinical trial data shows RAD 101 detects Brain Metastases

by

Radiopharm Theranostics (RAD:AU) has announced Clinical trial data shows RAD 101 detects Brain Metastases

Download the PDF here.

This post appeared first on investingnews.com
0
FacebookTwitterPinterestEmail

Related Posts

Sarama Completes Tranche 2 Options Placement

Panelists: Gold “Essential” to Own as Volatility Rises...

Crypto Market Recap: Saylor’s Strategy Resumes Bitcoin Buying

Skyharbour Announces Closing of Option and Purchase Agreements...

What Factors Impact Graphene Cost?

Positive Uranium Leach Test Results at Lo Herma

Disclaimer: smartearns.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2024 smartearns.com | All Rights Reserved